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ABSTRACT
Welding has been associated with neurobehavioral disorders. Welding fumes contain several metals including copper (Cu),
manganese (Mn), and iron (Fe) that may interact to influence welding-related neurotoxicity. Although welding-related
airborne Fe levels are about 10-fold higher than Mn, previous studies have focused on Mn and its accumulation in the basal
ganglia. This study examined differences in the apparent transverse relaxation rates [R2* (1/T2*), estimate of Fe accumulation]
in the basal ganglia (caudate nucleus, putamen, and globus pallidus) between welders and controls, and the dose–response
relationship between estimated Fe exposure and R2* values. Occupational questionnaires estimated recent and lifetime Fe
exposure, and blood Fe levels and brain magnetic resonance imaging (MRI) were obtained. Complete exposure and MRI R2*
and R1 (1/T1: measure to estimate Mn accumulation) data from 42 subjects with welding exposure and 29 controls were
analyzed. Welders had significantly greater exposure metrics and higher whole-blood Fe levels compared with controls. R2* in
the caudate nucleus was significantly higher in welders after controlling for age, body mass index, respirator use, caudate R1,
and blood metals of Cu and Mn, whereas there was no difference in R1 values in the basal ganglia between groups. The R2* in
the caudate nucleus was positively correlated with whole-blood Fe concentration. This study provides the first evidence of
higher R2* in the caudate nucleus of welders, which is suggestive of increased Fe accumulation in this area. Further studies
are needed to replicate the findings and determine the neurobehavioral relevance.
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Welding has been associated with neurobehavioral disorders
(Cersosimo and Koller, 2006). Welding fumes contain several
metals originating from the electrodes and base metals, and
previous studies suggest that these metal mixtures may inter-
act to cause welding-related toxicity, especially for welders with
chronic exposure (Lu et al., 2005). Iron (Fe), copper (Cu), and
manganese (Mn) are among the major elements in many types
of welding fumes (Burgess and Burgess, 1995). Although air-
borne Fe concentrations are about ten-fold greater than those of
Mn (Ellingsen et al., 2006; Flynn and Susi, 2009) and whole blood
Fe levels are much higher than those of Mn (Lu et al., 2005), past
welding-related studies have focused on Mn accumulation in
brain (Choi et al., 2007; Lee et al., 2015) with few studies examin-
ing brain deposition of Fe in welders or mine workers (Criswell
et al., 2015; Long et al., 2014).
The major route of inhaled Fe into the brain is via the blood-
brain-barrier (BBB), although Fe also can enter the brain via the
blood–cerebrospinal fluid (CSF) barrier and perhaps olfactory
pathways (Yokel, 2006). Influx of Fe into the brain is carrier-
mediated, but Fe efflux is not fully understood (Ward et al., 2014).
Fe uptake into brain is affected by several factors including par-
ticle size and the presence of other metals such as Mn and Cu.
For example, Fe and Mn may compete for common transporters
[e.g., transferrin and/or divalent metal transporter-1 (DMT1)]
(Erikson et al., 2004), and Cu overload may decrease Fe brain up-
take (Crowe and Morgan, 1996). Thus, increased levels of weld-
ing-related metals other than Fe (e.g., Mn, Cu, etc.) may influence
its uptake into the brain and vice versa. Brain Fe distribution has
regional specificity, with the highest concentrations found in the
extrapyramidal system, less in the cerebral cortex, and least in
the prefrontal cortex. Among the structures in the extrapyram-
idal system, the basal ganglia have the highest Fe concentration
(primarily the globus pallidus [GP]), followed by putamen (PUT)
and caudate nucleus (CN) (Hallgren and Sourander, 1958).
Similar to Mn, Fe is an essential element that can be neuro-
toxic at higher doses (Sipe et al., 2002). It has long been known
that brain deposition of Fe increases with aging (Hallgren and
Sourander, 1958), and Fe overload in the brain is associated with
neurodegenerative disorders (Wallis et al., 2008; Ward et al.,
2014). Indeed, pathological studies have demonstrated
increased Fe accumulation in the substantia nigra of
Parkinson’s patients (Dexter et al., 1991; Sofic et al., 1991).
In magnetic resonance imaging (MRI), Fe has paramagnetic
characteristics and shortens the apparent transverse relaxation
time (T2*; Haacke et al., 2005). Thus, one of the commonly used
methods to assess Fe accumulation in human brain is measure-
ment of the T2* relaxation rate [R2* (1/T2*)]. Indeed, several neuroi-
maging studies (Gelman et al., 1999; Peran et al., 2010) established
associations between R2* values in selected brain areas (including
the basal ganglia) and brain Fe content estimated from the post-
mortem data of Hallgren and Sourander (1958). Other neuroimag-
ing studies have shown increased R2* in the substantia nigra of
Parkinson’s patients (Du et al., 2011; Ulla et al., 2013). R2* may be,
however, affected by the presence of other paramagnetic metals
(e.g., Cu and Mn) that are common in welding (Vymazal et al.,
1993). For example, increased R1 and R2 values occurred when
there was elevated Mn exposure without additional Fe (Fitsanakis
et al., 2010).
Studies examining Fe brain accumulation in welding or Mn ex-
posure are sparse and inconsistent. Long et al. (2014) assessed Fe
concentration via T2* and, when compared to controls, found
full-time welders had lower T2* in the frontal cortex, but no differ-
ence in selected subcortical regions of interests (ROIs; e.g., GP,
thalamus, and hippocampus). A recent study in deceased mine
workers reported no differences in Fe tissue concentrations in the
basal ganglia compared to controls (Criswell et al., 2015), although
increased Fe tissue concentration was reported in the basal gan-
glia of Mn-exposed monkeys (Olanow et al., 1996).
In the present study, two hypotheses were tested based on
the associations between high welding exposure and disorders of
the basal ganglia. First, in welders with chronic, low level expos-
ure, there will be higher R2* values in the basal ganglia structures
(CN, PUT, and GP) when compared to controls. Second, if the first
hypothesis is true, the increased R2* values will be positively cor-
related with increased Fe exposure assessed by exposure metrics
and blood Fe levels. We also explored the associations between
R2* and other welding-related metals such as Cu and Mn.
METHODS
Subjects. Eighty-one subjects were recruited from meetings of
regional unions in Philadelphia and Harrisburg, PA, USA, and
from the community around the Penn State Hershey Medical
Center (HMC). Welders were defined as subjects who had
welded at any point during their lifetime and controls were
those who did not. Detailed demographic information was
obtained from all subjects. This included age, education, history
of smoking, and current and/or past major medical/neurological
disorders. All subjects were examined and ascertained to be
free of any obvious neurological and movement deficits using
the Unified Parkinson’s Disease Rating Scale-motor scores
(UPDRS-III) with threshold score of <15 (Lee et al., 2015). All sub-
jects had normal blood calcium and magnesium levels, and no
Fe deficiency. All welders underwent an orbital radiograph to
rule out any metal fragments around the eye. Written informed
consent was obtained from all subjects in accordance with
guidelines approved by the Internal Review Board/Human
Subjects Protection Office of the Penn State HMC.
One welder failed to complete the MRI acquisition. Six weld-
ers and three controls had poor quality R2* images and thus the
data from these subjects were excluded. The final data set
included 29 controls without history of welding and 42 welders
(see demographic information in Table 1-A).
Welders represented several different trades and industry
groups (e.g., boilermakers, pipefitters, pile drivers, railroad
welders, and a variety of different manufacturing jobs). To
explore the nature of Fe accumulation in basal ganglia, the 42
welders were subdivided into two subgroups: welders with
recent exposure (Welding-Recent; N¼ 35) who had welded in
the 90 days prior to the MRI acquisition and welders without
exposure in the 90 days prior to the MRI (Welding-Not-Recent;
N¼ 7). Controls were age-matched volunteers from the com-
munity of the same region with various occupations.
Exposure assessment. Exposures were assessed by two question-
naires. The work history (WH; Lee et al., 2015) questionnaire was
designed to collect job information for the individual’s working
lifetime, with an emphasis on characterizing welding and other
jobs that may be associated with welding exposure. An addi-
tional supplementary exposure questionnaire (SEQ) focused on
the three-month period prior to the MRI, and determined the
time spent on welding, the type of metal welded, and the vari-
ous types of welding performed. Information on respirator use,
confined space work, and use of ventilation also was collected.
The primary exposure metric derived from the SEQ was hours
welding, brazing, or soldering [HrsW¼ (weeks worked) (hrs/
week) (fraction of time worked that is directly related to weld-
ing); Lee et al., 2015] in the 90 day period preceding the MRI and
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blood draw. Responses to the WH enabled an estimate of the
cumulative lifetime years welding (YrsW¼ the Years spent
welding during the subjects’ life; Lee et al., 2015).
Blood analysis. Whole blood Cu, Fe, and Mn levels were assessed
as described in Lee et al. (2015). Plasma Fe, total Fe binding
capacity (TIBC; maximum amount of Fe needed to saturate
plasma transferrin), and percent transferrin saturation [meas-
ure of Fe that is actually bound to transferrin; (plasma Fe/
TIBC) 100] were measured at the Penn State HMC Clinical
Laboratory using a standardized protocol based on the absorb-
ance of ferrozine against known standards.
MRI image acquisition and analysis. All images were acquired
using a Siemens 3T scanner (Magnetom Trio, Siemens Medical
Solutions, Erlangen, Germany) with an 8-channel head coil.
First, high-resolution T1-weighted (T1W) and T2-weighted
(T2W) images were acquired for anatomical segmentation. T1W
images were collected using an MPRAGE sequence with
Repetition Time (TR)¼ 1540 ms, Echo Time (TE)¼ 2.3 ms, Field of
View (FoV ) ¼ 256 256 mm, matrix ¼ 256  256 mm, slice
thickness¼ 1 mm, slice number¼ 176 (with no gap), and voxel
spacing 1 1 1 mm. T2W images were collected using a fast-
spin-echo sequence with TR/TE¼ 2500/316, and the same spa-
tial resolution as the T1W images. A multigradient-echo
sequence was used to estimate the apparent transverse relaxa-
tion rate: R2* (1/T2*). Five echoes with TE ranging from 8 to
40 ms and an interval of 8 ms were acquired with TR¼ 51 ms,
flip angle¼ 15, FoV¼ 230 mm 230 mm, matrix¼ 256 256,
slice thickness ¼ 1.6 mm, and slice number¼ 88 with band-
width of 35.9 kHz. The middle slice of the image was placed on
the line between the anterior and posterior commissures.
Defining brain regions of interest. Bilateral basal ganglia structures
[GP, PUT, CN] were selected as ROIs (Dorman et al., 2006). ROIs
were defined for each subject using automatic segmentation
software (AutoSeg; Gouttard et al., 2007) and then were eroded by
1 voxel using a morphological operation in order to make sure
the segmented ROIs were within the anatomical ROIs (Figure 1).
The quality of the segmentation then was visually confirmed for
all subjects by a reviewer blinded to group assignment.
Estimation of R2* values. The magnitude images of multigradient-
echo images were used to generate R2* maps by using a voxel-
wise linear least-squares fit to a monoexponential function with
free baseline using in-house MATLAB (The MathWorks, Inc.,
Natick, MA) tools (see Supplementary Figure 1 for quality control
information of R2* maps). The automatically segmented ROIs
that were on the T1W images first were co-registered onto T2W
images, and then the ROIs on T2W image space were co-
registered again onto the R2* maps using an affine registration
implemented in 3D Slicer (www.slicer.org, accessed January 27,
2016; Rueckert et al., 1999). The last 3-4 inferior slices on the
transverse plane were manually deleted for all subjects in order
to ensure that the co-registered ROIs did not go beyond the lower
boundary of the anatomical ROIs (Supplementary Figure 2). The
R2* values of each ROI were calculated as 1/T2* in each voxel and
averaged over the entire ROI using a trimmed mean (5%–95%) to
reduce possible segmentation error and imaging noise.
Estimation of R1 values. First, whole brain T1 time images were
generated by the scanner. ROIs were co-registered onto the T1
maps using an affine registration implemented in 3D Slicer
(www.slicer.org; Rueckert et al., 1999). The R1 values in each ROI
were calculated as 1/T1 in each voxel and averaged over the
entire ROI using a trimmed mean (5%–95%), the same method
as used for the T1W intensities (Lee et al., 2015).
Statistical analysis. All error terms in the text, figures, and tables
are standard deviations. SAS 9.3 was used to perform all statisti-
cal analyses. Right- and left hemisphere MRI data were averaged
within each subject. One-way analysis of covariance (ANCOVA)
with t-distributed errors was used for any group comparisons in
order to account for outliers (Lange, 1989). For the between-group
comparisons of MRI R2*s or R1s, the analyses were adjusted by
using age, body mass index (BMI), respirator use, R1 or R2* values
for the corresponding ROI, and whole blood metal levels of Mn
and Cu as covariates. Because multiple brain areas were
compared, the Benjamini-Hochberg method (Benjamini and
Hochberg, 1995) was used to control the false discovery rate (FDR)
at the q¼ 0.05 level. We report raw p-values and indicate whether
the tests were significant at a FDR level of 0.05.
Welding-Recent and Welding-Not-Recent subjects were
examined using ANCOVA. Subgroup analyses were corrected
for multiple group (i.e., three) comparisons using the
Benjamini-Hochberg method. To explore any relationships
between R2* and exposure metrics, both Pearson (to examine a
linear relationship) and Spearman (to account for outliers) cor-
relation analyses were performed. Both correlations were per-
formed with adjustment of age in welders only because controls
had 0 HrsW and YrsW. To explore the relationships between R2*
and whole blood Fe levels, Pearson and Spearman partial corre-
lations were performed with adjustment for age, R1 values for
the corresponding ROI, and whole blood Mn and Cu levels for
subjects in the entire cohort and then for welders and controls
separately. Statistical significance was defined as a¼ 0.05. Due
to the exploratory nature of these analyses, they were not cor-
rected for multiple comparisons.
TABLE 1. Summary Statistics for Demographic and Exposure Metrics
(A) and Blood Metals (B) in Welders and Controls
Welders
(N¼ 42)
Controls
(N¼ 29)
Mean6SD Mean6SD P values
A. Demographic and exposure metrics
Age (years) 48.1611.2 44.06 11.5 .14
Education (years) 13.061.7 16.26 2.4 <.001***
HrsW (hours) 2296184 06 0 (0) <.001***
YrsW (years) 25.8611.1 06 0 (0) <.001***
ALT (IU/l) 39.4617.5 37.36 16.7 .23
BMI (kg/m2) 28.965.1 26.26 3.4 .04*
UPDRS-III 2.162.5 1.66 2.2 .24
B. Whole blood metals
Whole Cu (ng/mL) 8996113 7546 139 <.001***
Whole Mn (ng/mL) 10.863.2 8.56 2.1 .013*
Whole Fe (lg/mL) 560649 4966 77 <.001***
Plasma blood levels
Plasma Fe (lg/dl) 104638 1056 32 .97
Total_IBC (lg/dl) 324666 3216 52 .81
Transferrin saturation (%) 33613 336 10 .85
Hemoglobin (lg/dl) 15.261.0 14.86 0.8 .07
RBC (lg/dl) 5.060.4 5.06 0.3 .28
ALT, alanine aminotransferase; IBC, iron binding capacity.
*P<0.05, **P<0.01, ***P<0.001.
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RESULTS
Group Comparisons between All Welders and Controls
Demographic, exposure metrics, and blood Fe levels. As shown in
Table 1-A, there were no significant group differences in age, liver
function (ALT: alanine aminotransferase), or UPDRS-III scores.
Welders had a higher BMI (p¼ 0.04) and controls had more years
of education than welders (p< 0.001). Welders had significantly
greater HrsW, a short-term exposure metric, and YrsW, a long-
term exposure metric (p< 0.001; Table 1-A). Whole blood Fe
(5606 49 vs 4966 77lg/mL; p< 0.001), Cu (8996113 vs
7546139 ng/mL; p< 0.001), and Mn (10.863.2 vs 8.562.1 ng/mL;
p¼ 0.014) levels also were significantly higher in welders com-
pared with controls (Table 1-B). There were no significant group
differences in plasma Fe, TIBC, and transferrin saturation levels
(Table 1-B).
MRI R2* and R1 measurements in basal ganglia. As shown in Figure
2a, R2* in the CN was significantly greater in welders compared
to controls (p¼ 0.004) after controlling for age, BMI, respirator use,
FIG. 1. Automatically segmented basal ganglia ROI (CN, PUT, and GP) on T1-weighted MPRAGE images after erosion by 1 voxel for one representative welder (1a) and
one control (2a). ROIs co-registered and overlaid onto the R2* maps for welder (1b) and control (2b).
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R1 in the CN, and whole blood levels of Cu and Mn. This CN dif-
ference remained significant after correction for multiple com-
parisons. Comparison of R2* values in the PUT and GP between
welders and controls did not reach statistical significance, with
p¼ 0.12 for PUT and p¼ 0.48 for GP (Figure 2-A). As seen in Figure
2c, there were no group differences in R1 values of any ROI after
controlling for age, BMI, respirator use, R2* value of the corre-
sponding ROI, and blood metal levels of Cu and Fe (ps> 0.18).
The association of R2* measures in the basal ganglia with Fe exposure
estimates. The welder group showed no correlations between R2*
values in any ROI and HrsW or YrsW after controlling for age
(ps> 0.39). On the other hand, R2* values in the CN and GP were
correlated positively with whole blood Fe levels among all sub-
jects (Spearman; R¼ 0.35, p¼ 0.004 for CN and R¼ 0.30, p¼ 0.015
for GP) after controlling for age, the R1 value for the correspond-
ing ROI, and whole blood Cu and Mn levels. Within welders, R2*
in the CN was correlated positively with whole blood Fe level
(Spearman; R¼ 0.37, p¼ 0.021; Table 2-B and Figure 3-A).
For controls, R2* values in the GP were correlated positively
with blood Fe levels after adjustments for age, GP R1, and blood lev-
els of Cu and Mn (for both Pearson and Spearman, Rs> 0.41,
ps< 0.045), whereas R2* values in the CN and GP were correlated
negatively with blood Mn levels after controlling for age, R1 values
in the corresponding ROI, and blood levels of Cu and Fe (Spearman;
R¼0.40, p¼ 0.047 for CN and for both Pearson and Spearman:
Rs<0.57, ps< 0.003 for GP; Table 2 and Figure 3b-c).
Subgroup Comparisons among Controls, Welding-Not-Recent, and
Welding-Recent
Demographic, exposure metrics, and blood metal levels. As seen in
Table 3, both welding subgroups had greater YrsW compared to
controls (ps< 0.001). The Welding-Not-Recent subgroup was older
and had last welded between 5-180 months before participation.
The Welding-Not-Recent subgroup also had higher whole blood
Cu (8986 99 vs 7546139 ng/mL; p¼ 0.029) and Fe (5436 20 vs
4966 77lg/mL; p¼ 0.005) levels than controls. The Welding-
Recent subgroup had greater whole blood Fe levels (5636 53 vs
4966 77lg/mL; p< 0.001), along with increased whole blood Cu
(9006 117 vs 7546 139 ng/mL; p< 0.001) and Mn (10.66 2.9 vs
8.562.1 ng/mL; p¼ 0.01) levels compared with controls.
MRI R2* and R1 measurements in basal ganglia. As seen in Figure
2-B, R2* values in the CN were significantly greater in the
Welding-Recent subgroup compared to controls (p¼ 0.0007)
after controlling for age, BMI, respirator use, CN R1, and whole
blood levels of Cu and Mn. This CN difference remained signifi-
cant after correction for multiple group comparisons.
FIG. 2. (A) MRI apparent transverse relaxation rates (R2*) in basal ganglia ROI (CN, PUT, and GP) for welders and controls, and (B) for controls, Welding-Not-Recent, and
Welding-Recent subgroups. (C) MRI longitudinal relaxation rates (R1) in basal ganglia ROI for welders and controls, and (D) for controls, Welding-Not-Recent, and
Welding-Recent subgroups. Values are raw R2* means6SD. * indicates significance (p<0.05) after correction for multiple group comparisons using the Benjamin-
Hochberg method.
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TABLE 2. Pearson (A) and Spearman (B) Correlation Coefficients of R2* Values in Basal Ganglia Regions with Exposure Metrics and Whole Blood
Metals
Among All Subjects (N¼ 71) Welders (N¼ 42) Controls (N¼ 29)
R2* CN R2* PUT R2* GP R2* CN R2* PUT R2* GP R2* CN R2* PUT R2* GP
A. Pearson correlations
HrsW 0.12 0.09 0.04
YrsW 0.07 0.14 0.07
Cu 0.02 0.02 0.11 0.20 0.16 0.20 0.24 0.07 0.13
Fe 0.19 0.02 0.15 0.29 0.01 0.04 0.04 0.19 0.41*
Mn 0.15 0.06 0.16 0.15 0.15 0.06 0.38 0.20 0.57**
B. Spearman correlations
HrsW 0.19 0.20 0.03
YrsW 0.21 0.25 0.21
Cu 0.10 0.07 0.12 0.25 0.15 0.16 0.14 0.08 0.10
Fe 0.36** 0.10 0.30* 0.37* 0.03 0.21 0.10 0.15 0.51*
Mn 0.22 0.06 0.30* 0.10 0.11 0.11 0.40* 0.27 0.62**
Correlations between R2* values and exposure metrics were conducted with adjustments for age. Correlations between R2* values and whole blood Fe levels were con-
ducted with adjustments for age and whole blood metals Cu and Mn. For R2* values and blood Mn level correlations, blood Cu and Fe levels were included in the analy-
sis as covariates. For R2* values and blood Cu level correlations, blood Fe and Mn levels were used as covariates.
*p<0.05, **p<0.01
FIG. 3. Scatter plots show (A) ranked R2* in the CN (y-axis) versus ranked blood iron (Fe: x-axis) for controls and welders; (B)ranked R2* in the GP (y-axis) versus ranked
blood Fe (x-axis). R2* and blood Fe values were adjusted for age and whole Cu and Mn levels for (A) and (B); (C) ranked R2* in the GP (y-axis) and ranked blood Mn (x-
axis). R2* and blood Mn values were adjusted for age and blood levels of Cu and Fe.
TABLE 3. Summary Statistics for Demographic and Exposure Metrics (A) and Blood Metals (B) in the 3 Subgroups
A. Controls (N¼ 29) B. Welding-Not-Recent (N¼ 7) C. Welding-Recent (N¼ 35)
Mean6SD Mean6SD Mean6SD Significant Comparisons
A. Demographic and exposure metrics
Age (years) 44.0611.5 53.167.5 47.1611.6 A<B*; B>C
Education (years) 16.262.4 12.360.5 13.161.8 A>B*; A>C*
HrsW (hours) 060 060 2746168 A<C*; B<C*
YrsW (years) 060 27.1611.4 25.5611.2 A<C*; B<C*
ALT (IU/l) 37.3616.7 41.4612.8 38.9618.5
BMI 26.263.4 29.661.4 28.765.6 A<B
Hemoglobin 14.860.8 14.960.7 15.361.1 A<B; A<C
UPDRS-III 1.662.2 2.062.2 2.162.5
B. Blood Metals
Mn (ng/mL) 8.562.1 11.764.7 10.662.9 A<C*
Fe (lg/mL) 496677 543620 563653 A<B*; A<C*
Cu (ng/mL) 7546139 898699 9006117 A<B*; A<C*
*Indicates significance (p<0.05) after correction for multiple group comparisons using the Benjamin–Hochberg method.
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Comparisons of R2* values among controls and welding sub-
groups in the PUT and GP revealed no group differences
(ps> 0.16 for PUT and ps> 0.51 for GP). Although R2* values in
the CN seemed to be higher in the Welding-Not-Recent group,
this comparison did not reach statistical significance after
controlling for age, BMI, respirator use, CN R1, and whole blood
levels of Cu and Mn.
As seen in Figure 2d, R1 in the CN for the Welding-
Not-Recent subgroup was greater than that of controls
(p¼ 0.015); this remained significant after correction for multi-
ple group comparisons. Comparisons of R1 values among con-
trols and welding subgroups in the PUT and GP revealed no
differences after controlling for age, BMI, respirator use, the R2*
value of the corresponding ROI, and blood metal levels of Cu
and Fe (ps> 0.095).
The association of R2* measures in the basal ganglia with Fe exposure
estimates. There were no significant associations between R2*
measurements and exposure metrics in either welding sub-
group in any of the ROIs after controlling for age (ps> 0.17). R2*
values in the CN were, however, correlated positively with
whole blood Fe levels for the Welding-Recent subgroup
(Spearman; R¼ 0.40, p¼ 0.026). No other correlations within the
Welding-Recent subgroup were significant (ps> 0.15). Moreover,
there were no significant associations between R2* measure-
ments and blood Fe level in the Welding-Not-Recent subgroup
in any ROI (ps> 0.099).
DISCUSSION
Using R2* as a surrogate for Fe accumulation, our study of PA-
based cohort of welders and controls found that welders had
greater exposure metrics, higher whole blood Fe levels, and
higher R2* values in the basal ganglia compared to controls. In
addition, the imaging changes were selective for the CN, not
other regions of the basal ganglia. Whereas past welding-related
studies focused on Mn accumulation in the basal ganglia (pre-
dominantly in the GP), the present study is the first human
study to delineate increased R2* values in the basal ganglia (pre-
dominantly in the CN), which suggests higher Fe accumulation
in this region, and its association with blood Fe levels in asymp-
tomatic welders. Follow-up studies that provide insight into a
possible role of Fe in welding-related neurobehavioral disorders
are clearly important.
Increased Fe Exposure in Welders with Chronic, Low Level Exposure
Our welders averaged 229 welding hours in the past 90 days,
approximately equivalent to spending nearly half of their work-
time on welding (Lee et al., 2015). They also had an average of
25.8 lifetime welding years. Thus, our welders have the charac-
teristics of chronic but low-level welding exposure, different
from most previous studies that focused on high-level welding
exposure.
Despite relatively modest exposure, higher Fe exposure was
evidenced by both greater exposure metrics and higher whole
blood Fe levels, and even the Welding-Not-Recent subgroup
who had not welded for at least five months prior to the study
visit showed higher blood Fe (543620 lg/mL) compared to con-
trols (4966 77 lg/mL). This result is consistent with previous
reports that both airborne and blood Fe concentrations were
much higher than those of Mn in many types of welding
(Ellingsen et al., 2006), and underscore the importance of study-
ing the role of Fe in welding-related toxicity in relatively low-
exposed welders.
Blood Fe Homeostasis in Welders with Chronic, Low Level Exposure
Interestingly, although blood Fe levels were greater in welders,
plasma Fe levels were comparable to controls. This result is
consistent with previous studies suggesting whole blood metal
levels may be a better exposure biomarker than plasma or
serum metal levels (Costa and Aschner, 2014; Spahr et al., 1996),
especially when exposure is relatively low. This is probably
because the majority of Fe in the body (approximately 80%) is
bound to hemoglobin in red blood cells (RBC) and only a fraction
is found in plasma (Collings et al., 2013). In addition, the finding
of comparable plasma Fe levels may suggest that the body is
able to regulate Fe overload. This is important because Fe con-
tent in plasma (rather than RBCs) influences what is trans-
ported to other organs including the brain via the BBB or
choroid plexus (Yokel, 2006).
Higher R2* Values in Selective Basal Ganglia Structures in Welders
Along with increased exposure metrics and whole blood Fe lev-
els, welders also demonstrated significantly higher R2* values,
suggestive of elevated Fe accumulation, in the basal ganglia
after controlling for confounders including R1 values and blood
levels of Cu and Mn. R2* values were highest in the GP (followed
by PUT and CN) for both controls and welders, consistent with
the general Fe brain distribution patterns based on postmortem
data (Hallgren and Sourander, 1958). A significantly increased
R2* value in welders, however, was present only in the CN, not
the PUT or GP. The seemingly greater R2* value in the PUT of
welders failed to be significant perhaps because the increase is
due to aging rather than welding (Hallgren and Sourander,
1958). Also, note that the GP is the region where welding-related
Mn predominantly accumulates (Erikson et al., 2004; Kim et al.,
1999). Our data are consistent with Long et al. (2014) who did not
find significant difference in T2* (1/R2*) in the GP, but unfortu-
nately did not include the CN as an ROI and also did not control
for possible Mn brain accumulation effects on T2*.
It is unclear why higher R2* values were found in the CN and
not in the PUT and GP. A PET study reported that occupational
welders had decreased dopamine transporter density, particu-
larly in the CN but not the PUT (Criswell et al., 2011), suggesting
that dopaminergic terminal loss may share a similar pattern of
Fe accumulation. It also is possible that welding-related Fe
increases may be detected more easily in the CN than in the
PUT or GP because Fe levels in the CN are generally lower than
those in the PUT and GP (Hallgren and Sourander, 1958).
Previous studies have reported welding-induced executive
function and working memory deficits (Bowler et al., 2006; Park
et al., 2009). Note that the frontal cortex (Long et al., 2014) and
CN [regions reported as having increased welding-related Fe
brain deposition suggested by lower T2* and higher R2* values]
are areas often associated with similar types of cognitive per-
formance (Grahn et al., 2008). Future studies are needed to
investigate any potential connections between the cognitive
decline in welders and increased Fe deposition in these areas.
It is important to note that no differences in R1 values were
found between welders and controls. Subgroup analyses indi-
cated that only the Welding-Not-Recent subgroup showed
higher R1 values in the CN compared to controls, probably
because Mn may not accumulate in brain if the exposure level is
low (Lee et al., 2015). Note that the Welding-Recent subgroup
had an average 274 welding hours (past 90 days), indicating
low-level exposure. The Welding-Not-Recent subgroup may
have higher R1 values because subjects may have higher expo-
sure level when they welded.
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We demonstrated that higher R2* values in the CN were corre-
lated positively with blood Fe levels after controlling for age, R1
in the CN, and blood Mn and Cu levels. Along with the absence
of increased R1 values in any ROIs for welders, this suggests
that increased R2* may be associated with increased exposure
specifically to Fe. In addition, increased blood Fe levels were
observed in both Welding-Recent and Welding-Not-Recent sub-
groups, suggesting that the blood Fe levels may reflect lingering
long-term exposure effects. Although the Welding-Not-Recent
subgroup showed higher R2* values in the CN than controls,
this increase was not significant probably due to relatively small
sample size. The correlation between R2* values and YrsW was
also not significant. Although it is possible that the YrsW metric
is a poor measure of long-term exposure, it is unclear whether
the higher R2* values in the CN are associated with long-term or
short-term exposure effects. Further studies with larger sample
sizes and better exposure metrics (such as cumulative lifetime
hours of welding and on-site airborne Fe measures) are needed
to determine the exact nature of the R2* increase observed in
welders.
Roles of Other Welding-related Metals (e.g., Cu and/ or Mn) in R2*
Measures
We explored the associations between R2* values in the basal
ganglia and other welding-related metals such as Mn and/or Cu.
We found that R2* in the CN and GP was correlated negatively
with blood Mn, whereas R2* in the GP was correlated positively
with blood Fe in controls after adjustment for confounders
including R1 values and other blood metal levels. These results
suggest potential attenuation of Fe brain accumulation due to
Mn for those who have a well-regulated balance of Mn and Fe
concentrations in blood and brain. It is interesting that the neg-
ative correlations between R2* values and blood Mn are lacking
in welders. It is possible that in welders, physiological handling
is disrupted or more complicated, since all welding-related met-
als (e.g., Cu, Fe, and Mn) were elevated simultaneously. Previous
animal studies reported complex interactions between Mn and
Fe when content of both metals was increased (Fitsanakis et al.,
2010; Zhang et al., 2009), and Fitsanakis et al. (2010) reported
increased levels in both R1 and R2 values for rats exposed to Mn
without additional Fe exposure. The R2 values were even
greater when rats were exposed simultaneously to both Mn and
Fe, although brain Fe concentrations in those rats showed no
change (e.g., striatum) or even decreases (e.g., cerebellum and
cortex). More studies are needed to investigate the interactions
among multiple metal mixtures, their brain deposition, and
effects on MRI changes.
CONCLUSION
The present study demonstrated increased R2* values in the CN
concomitant with increased Fe exposure in chronic, low-
exposure, asymptomatic welders. The current findings of higher
R2* values in welders compared to controls after adjustment for
confounders (including R1 values and blood Cu and Mn levels),
suggest the Fe exposure–R2* association. Although it is impossi-
ble to measure actual brain metal content of the study cohort in
order to directly link Fe exposure and R2*, vast body of literature
unequivocally supports such a relationship. Considering the
involvement of the CN in neurobehavioral functions, this result
may suggest a potential role of Fe in welding-related neurobe-
havioral changes. These findings may guide future studies and
the development of occupation- and public health-related
polices involving welding exposure.
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